Article

Astigmatism is common

Nearly one-half of patients who require vision correction are significantly astigmatic in at least one eye, according to a study sponsored by Johnson & Johnson Vision Care and published in Eye & Contact Lens.

Jacksonville, FL-Nearly one-half of patients who require vision correction are significantly astigmatic in at least one eye, according to a study sponsored by Johnson & Johnson Vision Care and published in Eye & Contact Lens.

To conduct this study, researchers obtained a database of spectacle prescriptions from a United Kingdom optical retail chain, and calculated the prevalence of astigmatism for various thresholds by eye and by patient. The analysis included patients aged 8 to 70 years. Astigmatism of 0.75 D was used as the threshold for analysis.

Of the 11,624 patients in the database, nearly one-half (47.4%) demonstrated significant astigmatism (greater than or equal to 0.75 D) in at least one eye, and nearly one-quarter (24.1%) exhibited significant astigmatism in both eyes. This proportion was higher for patients with myopia, of whom 54.9% demonstrated astigmatism in at least one eye, and 31.7% in both eyes. The prevalence of astigmatism was about twice as high in myopia as in hyperopia and increased with spherical refractive error.

Of the 47.4% of patients who had astigmatism, nearly one-half had significant astigmatism in one eye only.

"These findings provide useful information on the proportion of potential soft contact lens wearers requiring an astigmatic correction," said co-author Graeme Young, PhD, FCOptom, DCLP.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
© 2025 MJH Life Sciences

All rights reserved.